Cidara Therapeutics Inc. (CDTX) NASDAQ

$0.88 0.04 (4.35%)

Market Cap: $76.31M

As of 03/28/24 09:44 AM EDT. Market open.

(CDTX)

Cidara Therapeutics Inc. (CDTX)
NASDAQ

$0.88
0.04 (4.35%)

Market Cap: $76.31M

As of 03/28/24 09:44 AM EDT. Market open.

Add to Portfolio

cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies. our first product candidate is cd101 iv, a potential once-weekly intravenous therapy being developed for the treatment and prevention of systemic fungal infections. our second ... read more

cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies. our first product candidate is cd101 iv, a potential once-weekly intravenous therapy being developed for the treatment and prevention of systemic fungal infections. our second product candidate, cd101 topical, is a topical formulation of cd101, the first topical application of the enchinocandin class of anti-fungals, for the treatment of vulvovaginal candidiasis, or vvc. in addition, we have developed a proprietary immunotherapy technology platform, cloudbreak™, which we use to create compounds designed to direct a patient’s immune cells to attack and eliminate pathogens that cause infectious disease. we are developing our first cloudbreak development candidate, c001, for the treatment of invasive aspergillosis. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Jeffrey Stein
Full Time Employees
81
CEO Compensation (Base)
$460,000
CEO Compensation (Total)
$1.82M
URL
Address
6310 Nancy Ridge Dr Ste 101, California, San Diego, 92121-3209.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Jeffrey Stein
Full Time Employees
81
CEO Compensation (Base)
$460,000
CEO Compensation (Total)
$1.82M
Address
6310 Nancy Ridge Dr Ste 101, California, San Diego, 92121-3209.
PRICE CHART FOR CIDARA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.86
Previous Close
$0.84
Days Range
$0.74 - $0.85
52 week range
$0.59 - $1.48
Volume
152,966
Avg. Volume (30 days)
577,900
Market Cap
$76.31M
Dividend Yield
-
P/E
(2.70)
Shares Outstanding
90,619,040
Open
$0.86
Previous Close
$0.84
Days Range
$0.74 - $0.85
52 week range
$0.59 - $1.48
Volume
152,966
Avg. Volume (30 days)
577,900
Market Cap
$76.31M
Dividend Yield
-
P/E
(2.70)
Shares Outstanding
90,619,040
FINANCIAL STATEMENTS FOR CIDARA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CIDARA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Stein JeffreyPresident & CEOMar 11, 2024 Option Exercise$0.6956,69239,1171,153,693Mar 12, 2024, 09:48 PM
Tari LeslieCHIEF SCIENTIFIC OFFICERMar 11, 2024 Sale$0.6721,02914,085258,681Mar 12, 2024, 09:48 PM
Sandison TaylorChief Medical OfficerMar 11, 2024 Sale$0.6720,66213,839347,095Mar 12, 2024, 09:47 PM
Ward ShaneCOO & CLOMar 11, 2024 Sale$0.6720,47313,713198,770Mar 12, 2024, 09:46 PM
Shah PreetamCFO & CBOMar 11, 2024 Sale$0.6718,93112,680227,210Mar 12, 2024, 09:45 PM
Tari LeslieCHIEF SCIENTIFIC OFFICERSep 11, 2023 Sale$0.9518,46917,509275,710Sep 13, 2023, 04:24 PM
Sandison TaylorChief Medical OfficerSep 11, 2023 Sale$0.9518,79317,810363,757Sep 13, 2023, 04:22 PM
Tari LeslieCHIEF SCIENTIFIC OFFICERAug 14, 2023 Buy$0.9710,0009,700294,179Aug 14, 2023, 07:40 PM
Stein JeffreyPresident & CEOAug 08, 2023 Buy$0.9650,00047,885331,602Aug 08, 2023, 06:04 PM
Stein JeffreyPresident & CEOMar 27, 2023 Buy$1.0450,00051,855281,602Mar 27, 2023, 07:03 PM
Ward ShaneCOO & CLOMar 13, 2023 Sale$1.534,3296,62384,576Mar 13, 2023, 09:21 PM
Tari LeslieCHIEF SCIENTIFIC OFFICERMar 13, 2023 Sale$1.537,56211,570190,179Mar 13, 2023, 09:21 PM
Shah PreetamCFO & CBOMar 13, 2023 Sale$1.536,64810,171148,141Mar 13, 2023, 09:20 PM
Sandison TaylorChief Medical OfficerMar 13, 2023 Sale$1.537,20311,021288,550Mar 13, 2023, 09:19 PM
Tari LeslieCHIEF SCIENTIFIC OFFICERJan 12, 2023 Sale$1.2011,81414,1771,484Jan 27, 2023, 04:33 PM
Shah PreetamCFO & CBOSep 19, 2022 Sale$0.7715,64212,035150,789Sep 19, 2022, 08:28 PM
Sandison TaylorChief Medical OfficerSep 12, 2022 Sale$0.6818,47812,656291,753Sep 13, 2022, 06:51 PM
Tari LeslieCHIEF SCIENTIFIC OFFICERSep 12, 2022 Sale$0.6818,15912,437193,741Sep 13, 2022, 06:48 PM
Daruwala PaulChief Operating OfficerSep 12, 2022 Sale$0.6816,19911,095221,099Sep 13, 2022, 06:40 PM
Shah PreetamCFO & CBOMar 31, 2022 Option Exercise$0.8324,82020,601112,431Apr 04, 2022, 05:21 PM
Ward ShaneCHIEF LEGAL OFFICERMar 31, 2022 Option Exercise$0.8323,12219,19180,905Apr 04, 2022, 05:12 PM
Stein JeffreyPresident & CEOMar 31, 2022 Option Exercise$0.83140,985117,018922,635Apr 04, 2022, 05:09 PM
Johnson BradyVice President, FinanceMar 21, 2022 Sale$0.8165453049,366Mar 23, 2022, 06:11 PM
Johnson BradyVice President, FinanceMar 11, 2022 Sale$0.7194567150,020Mar 11, 2022, 08:29 PM
Daruwala PaulChief Operating OfficerJan 05, 2022 Sale$1.255,1336,416187,298Jan 07, 2022, 08:26 PM
Johnson BradyVice President, FinanceJan 05, 2022 Sale$1.2541652050,965Jan 07, 2022, 08:23 PM
Tari LeslieChief Scientific OfficerJan 05, 2022 Sale$1.251,2521,565155,400Jan 07, 2022, 08:20 PM
Stein JeffreyPresident & CEONov 12, 2021 Buy$1.5950,00079,530465,878Nov 15, 2021, 06:41 PM
Shah PreetamCFO & CBONov 12, 2021 Buy$1.5420,00030,80020,000Nov 15, 2021, 06:38 PM
Franson Timothy RDirectorSep 13, 2021 Buy$2.127,00014,82311,000Sep 14, 2021, 07:59 PM
Stein JeffreyPresident & CEOAug 19, 2021 Buy$1.7910,00017,871415,878Aug 19, 2021, 04:24 PM
Stein JeffreyPresident & CEOAug 18, 2021 Buy$1.7240,00068,884405,878Aug 19, 2021, 04:24 PM
Daruwala PaulChief Operating OfficerJan 05, 2021 Sale$2.062,8685,90849,724Apr 05, 2021, 06:17 PM
Daruwala PaulChief Operating OfficerApr 01, 2021 Sale$2.665931,57750,531Apr 05, 2021, 06:17 PM
Oien JessicaGeneral Counsel & SecretaryApr 01, 2021 Sale$2.661,1773,1317,764Apr 05, 2021, 05:35 PM
Oien JessicaGeneral Counsel & SecretaryJan 05, 2021 Sale$2.068241,6976,141Apr 05, 2021, 05:35 PM
Stein JeffreyPresident & CEONov 10, 2020 Buy$2.0050,000100,015347,878Nov 12, 2020, 06:00 AM
Levine James E.Chief Financial OfficerNov 10, 2020 Buy$2.0150,000100,72050,000Nov 12, 2020, 06:00 AM
Abdollahian NeilChief Business OfficerJan 03, 2020 Sale$3.429403,21550,308Jun 25, 2020, 08:03 PM
Daruwala PaulChief Operating OfficerJan 03, 2020 Sale$3.429403,21552,592Jun 25, 2020, 08:01 PM
Levine James E.Chief Financial OfficerSep 24, 2019 Buy$1.9130,00057,24030,000Mar 23, 2020, 07:12 PM
Sandison TaylorChief Medical OfficerFeb 10, 2020 Option Exercise$2.516,11515,34973,331Feb 11, 2020, 06:46 PM
Sandison TaylorChief Medical OfficerFeb 07, 2010 Option Exercise$2.514,59411,53167,216Feb 11, 2020, 06:46 PM
Stein JeffreyPresident & CEOJan 29, 2020 Option Exercise$2.5132,28381,030257,902Jan 30, 2020, 08:50 PM
Stein JeffreyPresident & CEOJan 29, 2020 Option Exercise$2.517,55818,971293,878Jan 30, 2020, 08:50 PM
Levine James E.Chief Financial OfficerJan 28, 2020 Option Exercise$2.516,89117,296211,891Jan 30, 2020, 08:49 PM
Oien JessicaGeneral Counsel & SecretaryJan 02, 2020 Sale$3.868343,2196,965Jan 06, 2020, 05:28 PM
Abdollahian NeilChief Business OfficerJan 03, 2020 Sale$3.422,3408,00351,248Jan 06, 2020, 05:27 PM
Daruwala PaulChief Operating OfficerJan 03, 2020 Sale$3.422,3408,00353,532Jan 06, 2020, 05:26 PM
Daruwala PaulChief Operating OfficerOct 02, 2019 Sale$1.883,2956,19555,872Oct 03, 2019, 09:15 PM
Abdollahian NeilChief Business OfficerOct 01, 2019 Sale$1.987,28414,42249,588Oct 03, 2019, 09:13 PM
Oien JessicaGeneral Counsel & SecretarySep 27, 2019 Sale$1.861,0011,8627,799Oct 01, 2019, 05:07 PM
Stein JeffreyPresident & CEOSep 24, 2019 Buy$1.9152,500100,102225,619Sep 26, 2019, 09:23 PM
Levine James E.Chief Financial OfficerSep 24, 2019 Buy$1.9130,00057,240205,000Sep 26, 2019, 09:17 PM
Abdollahian NeilChief Business OfficerMar 08, 2019 Sale$2.442,3005,61230,472Mar 08, 2019, 07:30 PM
Daruwala PaulChief Operating OfficerMar 07, 2019 Sale$2.552,2405,71449,567Mar 08, 2019, 07:29 PM
Stein JeffreyPresident & CEOMay 23, 2018 Buy$4.70212,7661,000,000268,320May 24, 2018, 05:16 PM
BIOTECH TARGET N V10% OwnerNov 15, 2017 Buy$7.5760,000453,9662,295,272Nov 16, 2017, 12:19 PM
Stein JeffreyPresident & CEOSep 12, 2017 Buy$6.797,35049,90651,851Sep 12, 2017, 05:49 PM
Sandison TaylorChief Medical OfficerJun 06, 2017 Buy$5.906563,8706,351Jun 08, 2017, 04:40 PM
Sandison TaylorChief Medical OfficerJun 07, 2017 Buy$5.9019,344114,13025,695Jun 08, 2017, 04:40 PM
Stein JeffreyPresident & CEOJun 05, 2017 Buy$5.9515,00089,21144,501Jun 07, 2017, 04:45 PM
Stein JeffreyPresident & CEOMar 31, 2017 Buy$7.7512,90099,97527,196Apr 04, 2017, 04:33 PM
Forrest KevinCOO & CFOMay 20, 2016 Buy$11.534,35650,22558,253May 23, 2016, 04:34 PM
Stein JeffreyPresident & CEOMay 20, 2016 Buy$11.514,31049,608203,697May 23, 2016, 04:32 PM
Stein JeffreyPresident & CEONov 25, 2015 Buy$15.601,30020,2806,700Nov 27, 2015, 05:33 PM
Stein JeffreyPresident & CEONov 24, 2015 Buy$14.975,40080,8385,400Nov 27, 2015, 05:33 PM
Forrest KevinCOO & CFONov 23, 2015 Buy$14.237,087100,84851,719Nov 23, 2015, 07:18 PM
Heron Patrick JDirectorApr 20, 2015 Buy$16.00200,0003,200,000155,645Apr 22, 2015, 02:49 PM
Kjellson Nina SDirectorApr 20, 2015 Buy$16.00200,0003,200,000200,000Apr 22, 2015, 02:45 PM
Stein JeffreyPresident & CEOApr 20, 2015 Buy$16.004206,720420Apr 21, 2015, 03:35 PM
PEREZ ROBERT JDirectorApr 20, 2015 Buy$16.005,00080,0005,000Apr 21, 2015, 03:32 PM
Franson Timothy RDirectorApr 20, 2015 Buy$16.004,00064,0004,000Apr 21, 2015, 03:31 PM
BURGESS DANIEL DDirectorApr 20, 2015 Buy$16.003,00048,0003,000Apr 21, 2015, 03:29 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Stein JeffreyPresident & CEO03/11/202439,117
Tari LeslieCHIEF SCIENTIFIC OFFICER03/11/202414,085
Sandison TaylorChief Medical Officer03/11/202413,839
Ward ShaneCOO & CLO03/11/202413,713
Shah PreetamCFO & CBO03/11/202412,680
Tari LeslieCHIEF SCIENTIFIC OFFICER09/11/202317,509
Sandison TaylorChief Medical Officer09/11/202317,810
Tari LeslieCHIEF SCIENTIFIC OFFICER08/14/20239,700
Stein JeffreyPresident & CEO08/08/202347,885
Stein JeffreyPresident & CEO03/27/202351,855
Ward ShaneCOO & CLO03/13/20236,623
Tari LeslieCHIEF SCIENTIFIC OFFICER03/13/202311,570
Shah PreetamCFO & CBO03/13/202310,171
Sandison TaylorChief Medical Officer03/13/202311,021
Tari LeslieCHIEF SCIENTIFIC OFFICER01/12/202314,177
Shah PreetamCFO & CBO09/19/202212,035
Sandison TaylorChief Medical Officer09/12/202212,656
Tari LeslieCHIEF SCIENTIFIC OFFICER09/12/202212,437
Daruwala PaulChief Operating Officer09/12/202211,095
Shah PreetamCFO & CBO03/31/202220,601
Ward ShaneCHIEF LEGAL OFFICER03/31/202219,191
Stein JeffreyPresident & CEO03/31/2022117,018
Johnson BradyVice President, Finance03/21/2022530
Johnson BradyVice President, Finance03/11/2022671
Daruwala PaulChief Operating Officer01/05/20226,416
Johnson BradyVice President, Finance01/05/2022520
Tari LeslieChief Scientific Officer01/05/20221,565
Stein JeffreyPresident & CEO11/12/202179,530
Shah PreetamCFO & CBO11/12/202130,800
Franson Timothy RDirector09/13/202114,823
Stein JeffreyPresident & CEO08/19/202117,871
Stein JeffreyPresident & CEO08/18/202168,884
Daruwala PaulChief Operating Officer01/05/20215,908
Daruwala PaulChief Operating Officer04/01/20211,577
Oien JessicaGeneral Counsel & Secretary04/01/20213,131
Oien JessicaGeneral Counsel & Secretary01/05/20211,697
Stein JeffreyPresident & CEO11/10/2020100,015
Levine James E.Chief Financial Officer11/10/2020100,720
Abdollahian NeilChief Business Officer01/03/20203,215
Daruwala PaulChief Operating Officer01/03/20203,215
Levine James E.Chief Financial Officer09/24/201957,240
Sandison TaylorChief Medical Officer02/10/202015,349
Sandison TaylorChief Medical Officer02/07/201011,531
Stein JeffreyPresident & CEO01/29/202081,030
Stein JeffreyPresident & CEO01/29/202018,971
Levine James E.Chief Financial Officer01/28/202017,296
Oien JessicaGeneral Counsel & Secretary01/02/20203,219
Abdollahian NeilChief Business Officer01/03/20208,003
Daruwala PaulChief Operating Officer01/03/20208,003
Daruwala PaulChief Operating Officer10/02/20196,195
Abdollahian NeilChief Business Officer10/01/201914,422
Oien JessicaGeneral Counsel & Secretary09/27/20191,862
Stein JeffreyPresident & CEO09/24/2019100,102
Levine James E.Chief Financial Officer09/24/201957,240
Abdollahian NeilChief Business Officer03/08/20195,612
Daruwala PaulChief Operating Officer03/07/20195,714
Stein JeffreyPresident & CEO05/23/20181,000,000
BIOTECH TARGET N V10% Owner11/15/2017453,966
Stein JeffreyPresident & CEO09/12/201749,906
Sandison TaylorChief Medical Officer06/06/20173,870
Sandison TaylorChief Medical Officer06/07/2017114,130
Stein JeffreyPresident & CEO06/05/201789,211
Stein JeffreyPresident & CEO03/31/201799,975
Forrest KevinCOO & CFO05/20/201650,225
Stein JeffreyPresident & CEO05/20/201649,608
Stein JeffreyPresident & CEO11/25/201520,280
Stein JeffreyPresident & CEO11/24/201580,838
Forrest KevinCOO & CFO11/23/2015100,848
Heron Patrick JDirector04/20/20153,200,000
Kjellson Nina SDirector04/20/20153,200,000
Stein JeffreyPresident & CEO04/20/20156,720
PEREZ ROBERT JDirector04/20/201580,000
Franson Timothy RDirector04/20/201564,000
BURGESS DANIEL DDirector04/20/201548,000
Load More Insider Transactions
FUNDS WITH A POSITION IN CIDARA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC1,802,1730.00221%12.66%Other
BLACKROCK INC.938,1610.00002%-0.54%Other
GEODE CAPITAL MANAGEMENT, LLC805,8710.00007%No changeOther
CHANGE IN SHARES OUTSTANDING FOR CIDARA THERAPEUTICS INC
STOCK BUYBACKS FOR CIDARA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.19%
1Q
09/30/2023
03/31/2023
-10.77%
2Q
09/30/2023
12/31/2022
25.54%
3Q
09/30/2023
09/30/2022
1.91%
4Q
09/30/2023
06/30/2022
30.60%
5Q
09/30/2023
03/31/2022
32.51%
6Q
09/30/2023
12/31/2021
72.13%
7Q
09/30/2023
09/30/2021
82.27%
8Q
09/30/2023
06/30/2021
52.20%
9Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.19%
1Q
03/31/2023
-10.77%
2Q
12/31/2022
25.54%
3Q
09/30/2022
1.91%
4Q
06/30/2022
30.60%
5Q
03/31/2022
32.51%
6Q
12/31/2021
72.13%
7Q
09/30/2021
82.27%
8Q
06/30/2021
52.20%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CIDARA THERAPEUTICS INC
LOADING...